Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Large-scale testing (Phase 3)Study completedNCT00003805What this trial is testingPrevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountWho this might be right forBone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Ended earlyNCT00354172What this trial is testingDonor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.Who this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 16
Early research (Phase 1)Study completedNCT00005967What this trial is testingTipifarnib in Treating Patients With Advanced Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Study completedNCT01241500What this trial is testingRandomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess BlastsWho this might be right forMyelodysplastic SyndromesMDSRAEB+1 more Traws Pharma, Inc. 299
Early research (Phase 1)Study completedNCT01120457What this trial is testingFirst in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell CancersWho this might be right forAcute Myelogenous LeukemiaDiffuse Large B-Cell LeukemiaChronic Lymphocytic Leukemia+1 more Bristol-Myers Squibb 96